✦ LIBER ✦

Enhancement of C.E.V combination (cisplatin, epirubicin, vindesine) in advanced NSCLC by lonidamine. A phase II randomized trial

✍ Scribed by Ianniello, G.P.; De Cataldis, G.; Comella, P.; De Vita, F.; Maiorino, A.; Brancaccio, L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of combination chemother

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Combination of cisplatin, ifosfamide and

✍ Barón, FJ; Ceuva, JF; Vázquez, F; Candamio, S; Calvo, M; Menéndez, MD; Irigoyen, 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Phase II trial assessing the combination

✍ Antón, A; Dı́az-Fernández, N; González Larriba, J.L; Vadell, C; Masutti, B; Mont 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Phase II trial of oral vinorelbine in co

✍ Lena, M. De; Ramlau, R.; Hansen, O.; Lorusso, V.; Wagner, L.; Barni, S.; Cristov 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 162 KB

6512 A randomized phase II trial of two

✍ Cereda, S.; Reni, M.; Rognone, A.; Ghidini, M.; Rezzonico, S.; Passoni, P.; Mazz 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

159 Phase II trial of gemcitabine in com

✍ Mohedano, N.; Sanchez-Rovira, P.; Medina, B.; Flores-Gonzalez, E.; Moreno, M.A.; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 158 KB